Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

